Global Cord Blood Corporation (CORBF)
OTCMKTS
· Delayed Price · Currency is USD
1.250
-0.500 (-28.57%)
Oct 28, 2024, 10:02 AM EDT
Global Cord Blood Revenue
In the fiscal year ending March 31, 2022, Global Cord Blood had annual revenue of 1.24B CNY with 7.21% growth. Global Cord Blood had revenue of 297.21M in the quarter ending March 31, 2022, a decrease of -1.69%.
Revenue
1.24B CNY
Revenue Growth
+7.21%
P/S Ratio
0.77
Revenue / Employee
1.03M CNY
Employees
1,202
Market Cap
167.39M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2022 | 1.24B | 83.62M | 7.21% |
| Mar 31, 2021 | 1.16B | -61.82M | -5.06% |
| Mar 31, 2020 | 1.22B | 234.71M | 23.79% |
| Mar 31, 2019 | 986.75M | 49.99M | 5.34% |
| Mar 31, 2018 | 936.77M | 176.79M | 23.26% |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
| Mar 31, 2014 | Pro | Pro | Pro |
| Mar 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.69B |
| Ryman Healthcare Limited | 411.39M |
| Verano Holdings Corp. | 920.97M |
| Vireo Growth Inc. | 98.04M |
| Medexus Pharmaceuticals Inc. | 108.78M |
Global Cord Blood News
- 4 months ago - Global Cord Blood Corporation Investors With Losses Are Urged By The Schall Law Firm To Start Communication Be Mindful Of The Deadline In This Case - Accesswire
- 4 months ago - The Schall Law Firm Encourages Global Cord Blood Corporation Investors With Losses To Initiate Communication Be Conscious Of The Time Limit In This Situation - Accesswire
- 4 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines - CORBF - PRNewsWire
- 4 months ago - CO, CORBF DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – CO, CORBF - GlobeNewsWire
- 4 months ago - CORBF Investors Have Opportunity to Join Global Cord Blood Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
- 4 months ago - Investors Who Have Incurred Losses In Global Cord Blood Corporation Are Encouraged By The Schall Law Firm To Reach Out Please Be Mindful Of The Deadline In This Matter - Accesswire
- 4 months ago - Investors Who Have Sustained Losses In Global Cord Blood Corporation Are Urged By The Schall Law Firm To Make Contact Please Be Aware Of The Deadline In This Case - Accesswire
- 4 months ago - SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines – CORBF - GlobeNewsWire